Andrew Mazar from Evanston, IL

Us Patents

Nanoparticle Arsenic-Platinum Compositions
view source
US Patent:

20110020434, Jan 27, 2011
Filed:

Sep 8, 2010
Appl. No.:

12/877414
Inventors:

Thomas V. O'Halloran - Chicago IL, US
Haimei Chen - Chicago IL, US
Andrew Mazar - Highland Park IL, US
International Classification:

A61K 9/127
A61K 33/36
A61K 31/285
A61K 31/282
A61K 33/24
A61K 38/19
A61K 39/395
A61P 35/00
US Classification:

424450, 424623, 514504, 514492, 424649, 424 851, 4241301
Abstract:

The present invention relates to nanoparticle encapsulated arsenic and platinum compositions and methods of use thereof. In particular, the present invention provides co-encapsulation of active forms of arsenic and platinum drugs into liposomes, and methods of using such compositions for the diagnosis and treatment of cancer.

Compounds For The Treatment Of Myelofibrosis
view source
US Patent:

20230062278, Mar 2, 2023
Filed:

Dec 23, 2020
Appl. No.:

17/789321
Inventors:

- Fort Worth TX, US
Andrew MAZAR - Lake Forest IL, US
International Classification:

A61K 31/407
A61K 31/519
Abstract:

The present invention provides methods of treating myelofibrosis in a patient by administering to the patient a therapeutically effective amount of a 08K-3β inhibitor such as 3-(5-fluorobenzofuran-3-y1)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-y1)pynOle-2,5-dione, or a pharmaceutically acceptable salt thereof, optionally in combination with a therapeutically effective amount of a JAK inhibitor such as ruxolitinib, or a pharmaceutically acceptable salt thereof.

Nanoparticle Arsenic-Platinum Compositions
view source
US Patent:

20210251897, Aug 19, 2021
Filed:

Oct 3, 2019
Appl. No.:

16/592263
Inventors:

- Evanston IL, US
Haimei Chen - Evanston IL, US
Andrew Mazar - Highland Park IL, US
International Classification:

A61K 9/127
A61K 47/69
A61K 38/40
A61K 33/36
A61K 45/06
A61K 33/24
C07K 16/28
A61K 38/19
C07F 15/00
A61K 31/282
C07F 9/72
Abstract:

The present invention relates to nanoparticle encapsulated arsenic and platinum compositions and methods of use thereof. In particular, the present invention provides co-encapsulation of active forms of arsenic and platinum drugs into liposomes, and methods of using such compositions for the diagnosis and treatment of cancer.

Nanoparticle Arsenic-Platinum Compositions
view source
US Patent:

20140220115, Aug 7, 2014
Filed:

Apr 7, 2014
Appl. No.:

14/246678
Inventors:

- Evanston IL, US
Haimei Chen - Evanston IL, US
Andrew Mazar - Highland Park IL, US
Assignee:

NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:

A61K 9/127
C07F 15/00
C07F 9/72
A61K 31/282
US Classification:

424450, 514492, 556136, 556 30, 514504
Abstract:

The present invention relates to nanoparticle encapsulated arsenic and platinum compositions and methods of use thereof. In particular, the present invention provides co-encapsulation of active forms of arsenic and platinum drugs into liposomes, and methods of using such compositions for the diagnosis and treatment of cancer.

Resumes

Adjunct Professor, Pharmacology

view source

Location:

Wilmette, IL

Industry:

Pharmaceuticals

Work:

Feinberg School of Medicine Northwestern University
Adjunct Professor, Pharmacology
Northwestern University Jun 2009 - Aug 2016
Entrepeneur-In-Residence, Research Professor
Northwestern University Apr 2009 - Aug 2016
Director, Center For Developmental Therapeutics
Monopar Therapeutics Apr 2009 - Aug 2016
Co-Founder, Director, Chief Scientific Officer and Executive Vp, R and D
Actuate Therapeutics Apr 2009 - Aug 2016
Co-Founder, Principle Scientific Advisor

Education:

University of Illinois College of Medicine
Doctorates, Doctor of Philosophy, Biochemistry, Philosophy

Skills:

Drug Discovery
Lifesciences
Molecular Biology
Biotechnology
Drug Development
Oncology
Cancer
Pharmaceutical Industry
Biochemistry
Pharmacology
Clinical Research
Cell Biology
Regulatory Affairs
Drug Testing
Targeted Drug Delivery
Orphan Drugs
U.s. Food and Drug Administration
Cancer Therapeutics

Name / Title

Company / Classification

Phones & Addresses

Andrew P. Mazar

Tactic Pharma, LLC
Commercial Physical Research, Nsk

1007 Church St, Evanston, IL 60201
855 Middle Ave, Menlo Park, CA 94025
2215 Maple Ave, Evanston, IL 60201